Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="de Souza, Paul" or (type any "bookEditor journalEditor issueEditor" and editor="de Souza,...

Add to list
- Journal Article
- A1
- open access
Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors

Sylvie Rottey (UGent) , Jeffrey Clarke, Kyaw Aung, Jean-Pascal Machiels, Ben Markman, Kimberley M. Heinhuis, Michael Millward, Martijn Lolkema, Sandip Pravin Patel, Paul de Souza, et al.

(2022) CLINICAL CANCER RESEARCH. 28(1). p.95-105
Add to list
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Charles J Ryan, Matthew R Smith, Karim Fizazi, Fred Saad, Peter F A Mulders, Cora N Sternberg, Kurt Miller, Christopher J Logothetis, Neal D Shore, Eric J Small, et al.

(2015) LANCET ONCOLOGY. 16(2). p.152-160
Add to list
A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer

Luis Paz-Ares, Beatrix Bálint, Richard H de Boer, Jan Van Meerbeeck (UGent) , Rafal Wierzbicki, Paul De Souza, Francesco Galimi, Vincent Haddad, Tony Sabin, Yong-Jiang Hei, et al.

(2013) JOURNAL OF THORACIC ONCOLOGY. 8(3). p.329-337
Add to list
- Journal Article
- A1
- open access
Abiraterone in metastatic prostate cancer without previous chemotherapy

Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul Mainwaring, Josep M. Piulats, Siobhan Ng, et al.

(2013) NEW ENGLAND JOURNAL OF MEDICINE. 368(2). p.138-148

Academic Bibliography

Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer

Abiraterone in metastatic prostate cancer without previous chemotherapy

Contents

Support

Contact